MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202421038952 A) filed by Lupin Limited, Maharashtra, on May 17, 2024, for 'the novel rizatriptan nasal spray compositions.'
Inventor(s) include Sonawane, Shraddha; Mistry, Dhanashree; Gore, Subhash; and Thommandru, Vijaya Kumar.
The application for the patent was published on Nov. 21, under issue no. 47/2025.
According to the abstract released by the Intellectual Property India: "The invention provides stable nasal compositions including Rizatriptan or its pharmaceutically acceptable salts thereof. More specifically, the invention provides the low dose stable compositions of Rizatriptan or its pharmaceutically acceptable salts thereof. As per the important aspect of the invention, the inventors have provided the stable compositions containing one or more permeation enhancers, solvent(s) and/or co-solvent(s) or a combination thereof and other pharmaceutically acceptable excipients that provide the enhanced bioavailability of the drug. According to another aspect of the current invention, the stable nasal compositions of Rizatriptan or its pharmaceutically acceptable salts thereof containing relative quantities of permeation enhancers and solvent(s) and/or co-solvent(s) or a combination thereof are provided."
Disclaimer: Curated by HT Syndication.
